Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ART-PLAN

K-Number: K220813 · 2022-06-17

ApplicantTherapanacea
Decision Date2022-06-17
Product CodeQKB
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

ART-PLAN is a medical device manufactured by Therapanacea. It received FDA 510(k) clearance on 2022-06-17 under approval number K220813. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ART-PLAN?

ART-PLAN is a medical device that received FDA 510(k) clearance on 2022-06-17. It is manufactured by Therapanacea. The 510(k) number is K220813.

When was ART-PLAN approved by the FDA?

ART-PLAN received FDA 510(k) clearance on 2022-06-17, under approval number K220813.

What company makes ART-PLAN?

ART-PLAN is manufactured by Therapanacea.

What is the FDA product code for ART-PLAN?

The FDA product code for ART-PLAN is QKB.

Other Devices by Therapanacea

K202700ART-Plan K232479ART-Plan

Related Devices (Code: QKB)

K181572Workflow BoxMirada Medical, Ltd. K193562AI-Rad Companion Organs RTSiemens Medical Solutions USA, Inc. K200323AutoContourRadformation, Inc. K193252Contour ProtegeAIMim Software, Inc. K191928AccuContourXiamen Manteia Technology , Ltd. K213628VBrainVysioneer, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑